Poland· PL-100103493

Naproxen

A naproxen product containing naproxenum natricum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 2 of our 19 countries.

ATC M02AA12

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedNaproxenATCM02AA12REGISTER NO.PL-100103493PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Naproxen is registered in 2 of 19 countries.

Countries holding a registration under ATC M02AA12 (naproxen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Naproxen · ATC M02AA12

2 / 19 countries

  • Czechiaprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Naproxenum natricum
Manufacturer
Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
Country
Poland (PL)
ATC code
M02AA12
ATC class
Naproxen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990892419

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Naproxen in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All naproxen products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Aleve, Miranax
  • Belgium · Aleve, Apranax
  • Bulgaria · Налгезин, Налгезин Форте
  • Cyprus · Naprorex, Priaxen
  • Czechia · Emoxen, Nalgesin
  • Germany · Aspidolo, Dolormin Für Frauen Bei Menstruationsbeschwerden Mit
  • Denmark · Bonyl, Naproxen Evolan
  • Estonia · Emox, Nalgesin Forte
  • Spain · Actromadol, Antalgin
  • Finland · Miranax, Naprometin
  • France · Aleve, Alevetabs
  • United Kingdom (Northern Ireland) · Almus Period Pain Reliever, Boots Period Pain Reliever
  • Greece · Anaprox, Naprosyn
  • Croatia · Nalgesin, Nalgesin Forte
  • Hungary · Aleve, Aleve Extra
  • Ireland · Naprosyn Ec, Naproxen Azure Pharmaceuticals
  • Iceland · Naproxen Viatris, Naproxen-E Viatris
  • Italy · Dololibre, Femmedol
  • Lithuania · Emox, Nalgesin Forte
  • Luxembourg · Aleve, Apranax
  • Latvia · Emox, Nalgedol
  • Malta · Naprorex, Naprosyn
  • Netherlands · Aleve Classic Bij Pijn En Koorts, Aleve Feminax Bij Menstruatiepijn
  • Norway · Napren-E, Naproxen Evolan
  • Portugal · Actronadol, Ilgesin
  • Romania · Mobilat Pro, Naldorex
  • Sweden · Ipaflex, Naprocur
  • Slovenia · Nalgesin, Nalgesin Forte
  • Slovakia · Emoxen Gél, Nalgesin Forte

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/de98b6d9-b241-4c15-b237-4daf47f44ba9
GET /v1/drugs/de98b6d9-b241-4c15-b237-4daf47f44ba9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Żel",
  "source": "urpl",
  "strength": "12 mg/g",
  "packaging": "05909990892419 ¦ OTC ¦ 46904\n1 tuba 50 g",
  "substance": "Naproxenum natricum 1.2 g",
  "common_name": "Naproxenum natricum",
  "pl_product_id": "100103493",
  "pozwolenie_nr": "08924",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about naproxen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.